Table 1.
The demographic and clinical characteristics of participants
| Characteristics | Revision surgery (N = 22) | Omalizumab (N = 22) | P value |
|---|---|---|---|
| Sex | |||
| Male, n (%) | 11 (50.00) | 11 (50.00) | NS |
| Female, n (%) | 11 (50.00) | 11 (50.00) | |
| Age (years), mean SD | 44.18 10.77 | 46.50 12.11 | 0.5566 |
| BMI (kg/m2), median (IQR) | 23.75 (21.58–26.05) | 23.75 (21.80–27.45) | 0.9769 |
| IgE (kU/L), median (IQR) | 127.00 (58.43–317.80) | 167.50 (70.58–374.80) | 0.5677 |
| Region of residence | |||
| Urban, n (%) | 21 (95.45) | 21 (95.45) | NS |
| Rural, n (%) | 1 (4.55) | 1 (4.55) | |
| Education attainment | |||
| College and higher, n (%) | 15 (68.18) | 17 (77.27) | 0.4984 |
| Others, n (%) | 7 (31.2) | 5 (22.73) | |
| Smoking status | |||
| Never, n (%) | 16 (72.73) | 15 (68.18) | 0.6748 |
| Previous, n (%) | 4 (18.18) | 3 (13.64) | |
| Current, n (%) | 2 (9.09) | 4 (18.18) | |
| Comorbidity | |||
| Allergic rhinitis, n (%) | 20 (90.91) | 22 (100.00) | 0.4035 |
| Asthma, n (%) | 8 (36.36) | 22 (100.00) | |
| Atopic dermatitis, n (%) | 4 (18.18) | 6 (27.27) | |
| AERD, n (%) | 1 (4.55) | 0 (0.00) | |
| Otitis media, n (%) | 4 (18.18) | 4 (18.18) | |
| Allergic conjunctivitis, n (%) | 1 (4.55) | 2 (9.09) | |
| Salary monthly | |||
| less than 5000, n (%) | 6 | 2 | 0.2668 |
| 5000–10000, n (%) | 3 | 5 | |
| more than 10000, n (%) | 13 | 15 | |
| Current, n (%) | 2 (9.09) | 4 (18.18) |